semaglutide and general anesthesia Are Serious Risks of Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia Stopping GLP-1 Prior to Surgery:

If nausea occurs during titration, extending the time between dose increasesor holding at a current dose for an additional 12 weeksoften resolves symptoms without requiring medication discontinuation

The most effective drugs must reach the highest-need patients

INGREDIENTS L-carnitine L-tartrate (50%), bulking agent (cellulose gel), coating material [stabilisers (polyvinyl alcohol-polyethylene glycol- graft -co-polymer, polyvinyl alcohol), anti-caking agents (talc, mono- and diglycerides of fatty acids), colour (titanium dioxide)], anti-caking agents (magnesium salts of fatty acids, silicon dioxide)

The goal is simple: make access to medically guided treatment more efficient, while maintaining appropriate clinical oversight at every step